4 transcripts
NTRA
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
launched the Renasight test in 2020 for renal genetics, key trial data and now society guidelines have reinforced the importance of genetic testing
NTRA
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
genetic test for chronic kidney disease. We are pleased to see a recent guideline update from a leading medical society in nephrology. KDIGO, which
NTRA
Earnings call transcript
NASDAQ
2023 Q4
28 Feb 24
society guideline updates as early as this spring.
In oncology, we are working to expand MolDx coverage to several additional tumor types
NTRA
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
supporting expanded carrier screening 2021 and a positive statement from the National Society of Genetic Counselors earlier this year, we are hopeful
- Prev
- 1
- Next